Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
Nauzene
Synonyms :
atracurium
Class :
Antiemetic Agents
Brand Name :
Nauzene
Synonyms :
atracurium
Class :
Antiemetic Agents
Dosage Forms & Strengths Â
solution Â
10mg/mL Â
0.4-0.5 mg/kg IV over 1 minute as an initial dose 
0.08-0.1 mg/kg for maintenance dose
To maintain neuromuscular block 20-45 minutes after the initial dose, repeat the maintenance dose every 15-25 minutes as needed
If intubation is preceded by succinylcholine, the continuous infusion should be 0.005-0.01 mg/kg/min IV or 0.2-0.4 mg/kg IVP
Dosage Forms & Strengths Â
solution Â
10mg/mL Â
0.4-0.5 mg/kg IV over 1 minute as an initial dose 
0.08-0.1 mg/kg for maintenance dose
To maintain neuromuscular block 20-45 minutes after the initial dose, repeat the maintenance dose every 15-25 minutes as needed
When both drugs are combined, there may be an increased risk or severity of adverse effects  
when both drugs are combined, there may be an increased effect of atracurium  
when both drugs are combined, there may be an increased effect of atracurium
interaction of both drugs may lead to respiratory depression
interaction of both drugs may lead to respiratory depression
The interaction may enhance the risk of anaphylaxis
The interaction may enhance the risk of anaphylaxis
The interaction may enhance the risk of anaphylaxis
it may diminish the therapeutic efficacy when combined with castor oil
When atracurium is used together with bromisoval, the risk or seriousness of CNS depression is enhanced
When atracurium is used together with medazepam, the risk or seriousness of CNS depression is enhanced
The potential for CNS depression may enhanced when atracurium is used together with fencamfamin
When atracurium is used together with levosulpiride, the risk or seriousness of CNS depression is enhanced
When chlordiazepoxide is used together with atracurium, this leads to enhanced risk or seriousness of CNS depression
When atracurium is used together with melitracen, this leads to enhanced risk or seriousness of CNS depression
When atracurium is used together with isoflurophate, this leads to a reduction in the therapeutic effectiveness of atracurium
When emylcamate is used together with atracurium, this leads to enhanced risk or seriousness of CNS depression
When atracurium is used together with etizolam, this leads to enhanced risk or seriousness of CNS depression
When azatadine is used together with atracurium, this leads to enhanced risk or seriousness of adverse events
When acepromazine is used together with atracurium, this leads to enhanced risk or seriousness of CNS depression
When atracurium is used together with profenamine, this leads to enhanced risk or seriousness of adverse events
it may reduce the neuromuscular blocking effect of Neuromuscular Blocking Agents
it may reduce the neuromuscular blocking effect of Neuromuscular Blocking Agents
may increase the risk or severity of adverse effects when combined
may have an increased therapeutic efficacy when combined with atracurium besylate
may have an increased effect of CNS depression when combined with Atracurium besylate
the risk of CNS depression may be increased
the combination of ramosetron with atracurium may increase the chances of cns depression
the risk of adverse effects may be increased
the risk of CNS depression may be increased
the hazard or seriousness of cardiac arrhythmia can be heightened when atracurium is combined with digitoxin
Therapeutic activity of atracurium increased when combined with azlocillin.
May diminish the effects of pharmacodynamic antagonism
the risk of weakness and myopathy may be increased if atracurium is taken with fluocortolone
Adverse drug reactions Â
Frequency DefinedÂ
1-10% Â
Skin flush (5%) Â
<1% Â
Pruritus (0.2%) Â
Urticaria (0.1%) Â
Wheezing (0.2%) Â
Increased bronchial secretions (0.2%) Â
Erythema (0.6%) Â
Post-marketing Reports Â
Changes in heart rate (0.6-2.1%) Â
Bronchospasm (0.01%) Â
Erythema at the injection site Â
Cyanosis (0.001%) Â
Systemic vascular resistance changes Â
Cardiac arrest (0.001%) Â
Mean arterial pressure (1.9%) Â
Â
Pregnancy warnings:   
Pregnancy Category: CÂ
Lactation: Â
Excreted into human milk is unknown Â
Pregnancy Categories:       Â
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.  Â
Category B: there was no evidence of risk to the fetus in animal studies, and there were no enough studies on pregnant women. Â
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.   Â
Category D: adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.   Â
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.   Â
Category N: There is no data available for the drug under this category
Patient Information Leaflet   Â
Generic Name: atracuriumÂ
Why do we use atracurium? Â
atracurium is a Neuromuscular blocking agent. It is used to relax muscles during surgical procedure and while using a breathing machine.Â
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
